Quarterly report pursuant to Section 13 or 15(d)

CollabRx Acquisition (Tables)

v2.4.0.6
CollabRx Acquisition (Tables)
 9 Months Ended
Dec. 31, 2012
CollabRx Acquisition [Abstract]  
PURCHASE PRICE ALLOCATION FOR ACQUISITION OF COLLABRX
PURCHASE PRICE ALLOCATION FOR ACQUISITION OF COLLABRX
 
Assets acquired:
      
Developed Technology
   $ 720  
Customer Relationships
     433  
Trade Name
     346  
Non Compete Agreement
     151  
Cash
     476  
AP and accrueds
     (333 )
Deferred tax liability
     (664 )
Goodwill
     603  
         
Total Acquired Assets, net
   $ 1,732  
         
         
         
Purchase Price summary:
        
Common Stock Consideration
   $ 932  
Promissory Note Assumed
     500  
Loan/Note Payable Assumed
     300  
    $ 1,732